Heart failure & cardiomyopathies

Effectiveness and Safety of Ivabradine in Chinese Patients with Chronic Heart Failure: An Observational Study

ESC Heart FailPublished Prospective observational study

Authors' conclusion

Ivabradine treatment reduced HR and improved cardiac function and health-related quality of life in Chinese patients with chronic HF.

Study context

Population
Chinese patients with chronic heart failure (HF)
Participants
1,003 patients
Outcome
Change from baseline in HR, measured by pulse counting
Follow-up
1 and 6 months
Methodological detailsmulticentre, single-arm, post hoc analysis of angiotensin receptor-neprilysin inhibitor (ARNI) or beta-blocker combination
  • Multicentre
  • Single-arm
  • Post hoc analysis of ARNI or beta-blocker combination

Main finding

As reported in the abstract

Change in HR

Mean HR decrease at 1 month (b.p.m.)

12.9

Mean HR decrease at 6 months (b.p.m.)

16.1

Observational data: associations, not effects.

Further findings

Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical summary score (CSS) and overall summary score (OSS) improvement ≥5 points · Month 6

KCCQ CSS improvement ≥5 points
72.1%
KCCQ OSS improvement ≥5 points
74.1%
  • Both P < 0.001

LVEF change from baseline · Month 6

LVEF increase
12.1 ± 11.6
P
P < 0.001

New York Heart Association (NYHA) class · Month 6

Improvement in NYHA class
66.7%
P
P < 0.001
NYHA class III at month 6
13.5%
NYHA class IV at month 6
2.1%

Serum brain natriuretic peptide (BNP) and NT-proBNP change

BNP change
−331.9 ng/L (−1238.6, −134.0)
NT-proBNP change
−1113.8 ng/L (−2202.0, −297.2)
P
P < 0.001

HR, NYHA and KCCQ with vs without ARNI or beta-blocker (post hoc subgroup)

HR reductions and improvements in NYHA and KCCQ scores similar with and without ARNIs or beta-blockers
  • Post hoc analysis

Safety

Treatment-emergent adverse events (TEAEs) (498 events)
296 patients (29.5%)
Ivabradine-related TEAEs (73 events)
55 patients (5.5%)
Sinus bradycardia
7
Photopsia
7
Patients with TEAEs in ARNI and beta-blocker subgroups
21.9-35.6%

Original publication

Effectiveness and Safety of Ivabradine in Chinese Patients with Chronic Heart Failure: An Observational Study. ESC Heart Fail. Published 9 January 2024. doi:10.1002/ehf2.14581

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.